Fastsense Diagnostics is focused on developing low-cost high efficiency diagnostics devices for complex diseases such as cancer. Their current focus is to develop a hand-held portable electrochemical diagnostic/screening system for liver cancer. Cancer is a complex disease and there is no portable system is available for primary screening or monitoring. The proposed device will be critical in primary screening and monitoring of liver cancer in remote areas or resource-poor regions where even basic heath care facilities are not available. FastSense Diagnostics was founded by Dr. Preeti Joshi. The team has basic expertise in nanotechnology, electrochemistry, biomedical devices and electronics.
Vidcare Innovations is a startup trying to re-invent how diagnostics are performed by employing microfluidic principles, to develop an equipment-free, over the counter, quantitative immunoassay testing platform technology. The company, in the long run, envisions to empower people to diagnose for various medical conditions at home, with similar easy to use, rapid diagnostic products. Currently, the company is focused on solutions for maternal and child health, with the first offering being a TSH test for screening of hypothyroidism during pregnancy.
Early wound assessment and management is very crucial with the rise in Skin and Soft Tissue Infections (SSTI), ranging from diabetic foot ulcers, surgical site infections, burns, dermatology skin infections etc. Although it was estimated that an ankle is lost to diabetes somewhere in the world every 30 seconds, a more important fact is that up to 85% of all amputations in diabetes should be preventable. Conventional methods of SSTI monitoring are very ineffective. The problem is further compounded in low resource settings due to lack of quality infrastructure. Adiuvo Diagnostics is developing a non-invasive, portable Skin-Scope device to detect, classify major clinically relevant bacteria and fungus causing the infections in real time, and also access the rate of healing within 2 minutes. This will aid the doctors with early and right treatment protocol.
Altreal Bioinnovation Pvt Ltd is a spin-off based on CSIR-NCL’s capabilities and created under Lab2Mkt program of Venture Center. The aim of the startup is to develop affordable prostheses for rehabilitation for the Indian healthcare mass market. They are developing explant prosthetics such as nose , ear and eye based on silicone.
The company is a recipient of “Biotechnology Ignition Grant” of DBT-BIRAC, GoI.
Annweshan is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program. The company wishes to develop innovative health care & biotech products at affordable costs and commercialize these products. Currently Annweshan is working to develop a metabolite (non-nucleic acid) biomarker based novel TB diagnostic kit for sensitive (can detect MTB missed by smear microscopy), specific (to MTB in sputum samples), fast, easy, instrument- free, cheap and point-of-care detection of M. tuberculosis bacilli in patient’s sputum as well as severity of disease in patients. The company has received Biotechnology Ignition Grant by DBT-BIRAC, GoI
Actorius Innovations and Research Pvt Ltd (AIR) is a research and development company focused on creating novel biomaterials that have critical applications in the life science, drug delivery and medical diagnostics field. The company strives to develop in-house platform technologies that will fulfill a current need in medical procedure by improving upon an existing technology or device, or an unmet need that is clearly defined and acknowledged by medical professionals. AIR is founded by Dr. Jayant Khandare who is an NCL alumnus and Ex-Piramal Life Sciences, Dr. Muralidhara Padigaru who is also an ex-Piramal Life Sciences and Ph.D from PGIMER, Chandigarh. The third co-founder of AIR is Arvindan Vasudevan who has Master’s degree in Chemistry and a Certificate in Business Studies (Marketing).
AIR has received Biotechnology Ignition Grant and Small Business Innovation Research Initiative (SBIRI) grant by DBT-BIRAC, GoI.
Embryyo is a medical devices and healthcare solutions based company. They are working for devoloping innovative medical devices like Pill-box for TB drug adherance monitoring, non-invasive billirubin meter for neonatal jaundice, cervical cancer screening, etc for addressing women and maternal health, child health, public health. The company is Bill & melinda gates foundation grantee and winner of Grand challenges in TB control and Global health. Embryyo has also received SPARSH grant by DBT-BIRAC, GoI. They are the winner of USAID and “Innovator for Digital India Challenge”. Embryyo is founded by Nishant kumar who is an alumnus of IIT-Bombay and Ex-Philips Healthcare